Juan Pablo C. H.
- Country
- Spain
- Department
- Urological department
Research Overview
- Evaluation of Padeliporfin Vascular Targeted Photodynamic Therapy in Low-Grade Upper Tract Urothelial Carcinoma: A Phase 3 Multicenter Study
- Randomized Controlled Trial of Nadofaragene Firadenovec Versus Observation in Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Phase 3 Randomized Trial of Nadofaragene Firadenovec with Gemcitabine, Docetaxel, or Pembrolizumab in BCG-Unresponsive High-Grade NMIBC
Data & Insights
Has run more than one trial at 23 of 46 partner sites.
Specializations
Uro-oncology
Clinical research in bladder cancer, urothelial carcinoma, renal cell carcinoma, and prostate cancer, with interest in advanced and metastatic disease, non-muscle invasive bladder cancer, and locally advanced genitourinary malignancies.
- Urothelial carcinoma
- Renal cell carcinoma
- Non-muscle invasive bladder cancer
- Prostate cancer
Work in this area also includes treatment-resistant genitourinary tumors and perioperative strategies for recurrent or high-risk disease.
Breast and gynecologic oncology
Active involvement in breast cancer, ovarian cancer, endometrial cancer, and cervical cancer, spanning hormone receptor-positive, HER2-negative, triple-negative, and advanced gynecologic malignancies.
- Breast cancer
- Ovarian cancer
- Endometrial cancer
- Cervical cancer
Research interests extend to recurrent disease, metastatic settings, and biomarker-defined populations in women’s cancers.
Autoimmune and inflammatory disease
Clinical trial activity in systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and systemic sclerosis, reflecting a broad focus on immune-mediated rheumatic disorders.
- Systemic lupus erythematosus
- Lupus nephritis
- Rheumatoid arthritis
- Psoriatic arthritis
Additional interest is seen in hidradenitis suppurativa, atopic dermatitis, and vitiligo.
Cardiometabolic and renal medicine
Research involvement covers atherosclerotic cardiovascular disease, heart failure, hypertension, dyslipidemia, obesity, and type 2 diabetes, alongside kidney-focused conditions such as chronic kidney disease, IgA nephropathy, and focal segmental glomerulosclerosis.
- Atherosclerotic cardiovascular disease
- Heart failure
- Chronic kidney disease
- IgA nephropathy
This portfolio also includes lipid disorders, renal complications, and cardiovascular risk reduction in high-risk populations.
Oncology and hematology
Trial activity includes non-small cell lung cancer, colorectal cancer, pancreatic cancer, hepatocellular carcinoma, multiple myeloma, and lymphoma, with attention to advanced solid tumors and relapsed or refractory blood cancers.
- Non-small cell lung cancer
- Colorectal cancer
- Multiple myeloma
- Lymphoma
Research also spans myelodysplastic syndromes, acute leukemia, and other malignancies requiring novel therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.